Here are some of the hot stocks Jim Cramer talked about on Tuesday’s Mad Money on CNBC:
SPDR Gold Shares: Cramer once again recommended this ETF as the safest way to play gold, a commodity he said is heading higher in 2013. As Cramer says, the simple economics of gold say it's getting harder, and more costly, to find gold, which can only mean good things.
Regeneron Pharmaceuticals: Cramer interviewed this company’s CEO and once again recommended the stock because of its pipeline of new drugs. Cramer says the company continues to grow at 50 per cent a year and asked company president Dr. Leonard Schleifer whether his company's new cholesterol-lowering drugs could become bigger than its current Eylea eye-care treatment, Schleifer said he believes that it can.
Pfizer: Pfizer may be a sleepy drug stock, but Cramer and chartist Tim Collins think it’s headed higher in 2013. Cramer said he's already on record as saying Pfizer could repeat its 15 per cent gain from last year.
Biogen Idec: Cramer also interviewed this company’s CEO and came way as excited as ever about its life-altering drug pipeline, with treatments for multiple sclerosis, ALS and hemophilia in development or distribution.
To read a full recap of “Mad Money” on CNBC, click here .
Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive“Mad Money” Stock Screener.